top of page

Group

Public·10 members

On The Record Ka Linde Epub Bud



Deucravacitinib versus placebo and apremilast in moderate to severe plaque psoriasis: efficacy and safety results from the 52-week, randomized, double-blinded, placebo-controlled phase 3 POETYK PSO-1 trial.




On The Record Ka Linde Epub Bud


About

Welcome to the group! You can connect with other members, ge...
Group Page: Groups_SingleGroup
bottom of page